BMAL1 inhibits renal fibrosis and renal interstitial inflammation by targeting the ERK1/2/ELK-1/Egr-1 axis.
Chen W, Zhao S, Xing J, Yu W, Rao T, Zhou X, Ruan Y, Li S, Xia Y, Song T, et al. Int Immunopharmacol. 2023 Dec; 125(Pt B):111140. Epub 2023 Nov 10.